Afflatus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 15-11-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
as on 15-11-2024
- Satisfied Charges ₹ 3.00 Cr
as on 15-11-2024
- Revenue 42.27%
(FY 2023)
- Profit -144.82%
(FY 2023)
- Ebitda -244.94%
(FY 2023)
- Net Worth -27.42%
(FY 2023)
- Total Assets 35.27%
(FY 2023)
About Afflatus Pharmaceuticals
The Corporate was formerly known as Allenbury Biotech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Chhabra and Tilak Raj serve as directors at the Company.
- CIN/LLPIN
U00304DL2005PTC140510
- Company No.
140510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Afflatus Pharmaceuticals Private Limited offer?
Afflatus Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Ayurvedic, Herbal Oils and Cosmetics, Herbal Body Lotion, Ayurvedic & Herbal Health Supplement, Herbal Juice, Pharma Franchise, Ayurvedic PCD Pharma Franchise, Hair Oil, Herbal Hair Oil.
Who are the key members and board of directors at Afflatus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Chhabra  | Director | 23-Apr-2018 | Current |
| Tilak Raj | Director | 23-Apr-2018 | Current |
Financial Performance of Afflatus Pharmaceuticals.
Afflatus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.27% increase. The company also saw a substantial fall in profitability, with a 144.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Afflatus Pharmaceuticals?
In 2023, Afflatus Pharmaceuticals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Nov 2023 | ₹1.50 Cr | Open |
Others Creation Date: 01 Sep 2021 | ₹1.50 Cr | Open |
Others Creation Date: 17 Nov 2018 | ₹1.50 Cr | Open |
How Many Employees Work at Afflatus Pharmaceuticals?
Afflatus Pharmaceuticals has a workforce of 10 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Afflatus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Afflatus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
